SAİP, P. M. Et Al. 2011. Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .

SAİP, P. M., Eralp, Y., Ozkan, M., Karaca, H., Benekli, M., Cetin, B., ... Isikdogan, A.(2011). Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

SAİP, Pınar Et Al. "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

SAİP, Pınar M. Et Al. "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

SAİP, P. M. Et Al. (2011) . "Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

@article{article, author={Pınar Mualla SAİP Et Al. }, title={Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}